Literature DB >> 25457608

Susceptibility of enoxaparin reducing end amino sugars to periodate oxidation.

Anna Alekseeva1, Stefano Elli2, Cesare Cosentino2, Giangiacomo Torri2, Annamaria Naggi2.   

Abstract

There is a growing interest on glycol-split low-molecular weight heparins (gs-LMWHs), obtained by periodate oxidation of LMWHs, optionally followed by borohydride reduction, as potential anticancer and anti-inflammatory drugs. However, their structural characterization is still a challenging task, mainly because of the high microheterogeneity of the starting material. In addition, susceptibility to oxidation of some end-groups of LMWHs induces additional heterogeneity, making analysis of gs-LMWHs more complex. In our previous study we showed that 1,6-anhydro-d-mannosamine N-sulfate was affected by periodate, while its epimer 1,6-anhydro-d-glucosamine N-sulfate was resistant. In order to understand the apparently anomalous behavior of terminal 1,6-anhydro-d-mannosamine N-sulfate residues, in the present work we have studied by NMR spectroscopy and LC/MS the behavior of the reducing end amino sugar residues of the tetrasaccharides, isolated from the LMWH enoxaparin, in the presence of periodate. Their molecular mechanics conformational characterization has been also performed. We have shown that the C(2)-C(3) bond of the 1,6-anhydro-d-mannosamine residue can be split by periodate despite the N-substitution. Moreover, we have found that both terminal d-mannosamine N-sulfate and d-glucosamine N-sulfate, lacking the 1,6-anhydro-bridge, can be also oxidized by periodate but with a significantly lower rate. The present results suggest that the cis-e-/a-position of OH and NHSO3(-) groups of N-sulfated 1,6-anhydro-d-mannosamine is not the only factor that makes these end residues susceptible to the oxidation. The 1,6-anhydro-bridge that 'blocks' the ring conformation appears another crucial factor for oxidation to occur. Moreover, we have shown that controlling the reaction time could permit to selectively split non-sulfated iduronic acids of enoxaparin chains without oxidizing terminal amino sugar residues, a finding that may be useful to obtain more structurally homogeneous gs-LMHWs.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1,6-Anhydro-d-mannosamine; Enoxaparin; Glycol-split heparins; Low-molecular weight heparins; Periodate oxidation

Mesh:

Substances:

Year:  2014        PMID: 25457608      PMCID: PMC4254524          DOI: 10.1016/j.carres.2014.08.016

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  23 in total

1.  Quantum-Chemical Descriptors in QSAR/QSPR Studies.

Authors:  Mati Karelson; Victor S. Lobanov; Alan R. Katritzky
Journal:  Chem Rev       Date:  1996-05-09       Impact factor: 60.622

Review 2.  Structure and biological interactions of heparin and heparan sulfate.

Authors:  B Casu; U Lindahl
Journal:  Adv Carbohydr Chem Biochem       Date:  2001       Impact factor: 12.200

3.  Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation.

Authors:  Araz Jakalian; David B Jack; Christopher I Bayly
Journal:  J Comput Chem       Date:  2002-12       Impact factor: 3.376

4.  Prediction of protein retention times in anion-exchange chromatography systems using support vector regression.

Authors:  Minghu Song; Curt M Breneman; Jinbo Bi; N Sukumar; Kristin P Bennett; Steven Cramer; Nihal Tugcu
Journal:  J Chem Inf Comput Sci       Date:  2002 Nov-Dec

5.  Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.

Authors:  Anna Alekseeva; Benito Casu; Giuseppe Cassinelli; Marco Guerrini; Giangiacomo Torri; Annamaria Naggi
Journal:  Anal Bioanal Chem       Date:  2013-11-20       Impact factor: 4.142

6.  Low anticoagulant heparin disrupts Plasmodium falciparum rosettes in fresh clinical isolates.

Authors:  Anna M Leitgeb; Karin Blomqvist; Fidelis Cho-Ngwa; Moses Samje; Peter Nde; Vincent Titanji; Mats Wahlgren
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

7.  Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site.

Authors:  Tasneem Islam; Melissa Butler; Sulthan A Sikkander; Toshihiko Toida; Robert J Linhardt
Journal:  Carbohydr Res       Date:  2002-11-19       Impact factor: 2.104

Review 8.  Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.

Authors:  Benito Casu; Annamaria Naggi; Giangiacomo Torri
Journal:  Matrix Biol       Date:  2010-04-21       Impact factor: 11.583

9.  Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences.

Authors:  D R Ferro; A Provasoli; M Ragazzi; B Casu; G Torri; V Bossennec; B Perly; P Sinaÿ; M Petitou; J Choay
Journal:  Carbohydr Res       Date:  1990-01-15       Impact factor: 2.104

10.  Conversion of N-sulfated glucosamine to N-sulfated mannosamine in an unsaturated heparin disaccharide by non-enzymatic, base-catalyzed C-2 epimerization during enzymatic oligosaccharide preparation.

Authors:  S Yamada; M Watanabe; K Sugahara
Journal:  Carbohydr Res       Date:  1998-07       Impact factor: 2.104

View more
  1 in total

1.  MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides.

Authors:  Ditmer T Talsma; Felix Poppelaars; Wendy Dam; Anita H Meter-Arkema; Romain R Vivès; Peter Gál; Geert-Jan Boons; Pradeep Chopra; Annamaria Naggi; Marc A Seelen; Stephan P Berger; Mohamed R Daha; Coen A Stegeman; Jacob van den Born
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.